Point72 Asia (Singapore) Pte. Ltd. Enanta Pharmaceuticals Inc Transaction History

Point72 Asia (Singapore) Pte. Ltd.

  • $532 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.43 - $17.02 $124,404 - $185,245
-10,884 Reduced 43.17%
14,326 $186 Million
Q1 2024

May 15, 2024
BUY
$10.08 - $17.46 $242,020 - $419,214
24,010 Added 2000.83%
25,210 $440 Million
Q4 2023

Feb 14, 2024
BUY
$8.18 - $10.78 $9,816 - $12,936
1,200 New
1,200 $11.3 Million

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $178M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email